Samlyn Capital’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,065,935
| Closed | -$12.9M | – | 76 |
|
|
2025
Q1 | $12.9M | Sell |
4,065,935
-2,601,170
| -39% | -$8.27M | 0.19% | 68 |
|
|
2024
Q4 | $35.7M | Buy |
6,667,105
+2,136,772
| +47% | +$11.4M | 0.54% | 56 |
|
|
2024
Q3 | $23.9M | Sell |
4,530,333
-1,592,688
| -26% | -$8.41M | 0.36% | 65 |
|
|
2024
Q2 | $11.1M | Buy |
6,123,021
+3,774,658
| +161% | +$6.87M | 0.19% | 81 |
|
|
2024
Q1 | $4.18M | Sell |
2,348,363
-147,896
| -6% | -$263K | 0.07% | 87 |
|
|
2023
Q4 | $4.39M | Buy |
2,496,259
+90,495
| +4% | +$159K | 0.09% | 69 |
|
|
2023
Q3 | $3.51M | Buy |
2,405,764
+299,834
| +14% | +$438K | 0.06% | 89 |
|
|
2023
Q2 | $4.82M | Buy |
+2,105,930
| New | +$4.82M | 0.08% | 76 |
|